Telomerase and urological cancer
- Author:
Trieu Buu Nguyen
- Publication Type:Journal Article
- Keywords:
urological cancer
- MeSH:
Urologic Neoplasms;
Telomerase
- From:Journal of Preventive Medicine
2001;11(4):1-4
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Telomerase is a ribonucleoprotein enzyme. Which is responsible for catalyst for increasing chains of telomere and limitation of shortening the chromosome terminal head. Telomerase has activity for the primary cells but inhibited differentiate cells. Telomerase was considered most significantly as a marker of cancer because 90% of cancer cells in human had positive telomerase. The telomerase was used to early diagnose and monitor as well as predict outcome. The antitelomerase therapy was a proper method to prevent relapsed cancer after the traditional treatments